Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
54
BBP Quote, Financials, Valuation and Earnings
Last price:
$78.98
Seasonality move
:
1.24%
Day range:
$79.15 - $79.36
52-week range:
$48.65 - $80.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.6K
Avg. volume:
4.1K
1-year change:
21.93%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
-- | -- | -- | -- | -- |
|
PFFR
InfraCap REIT Preferred ETF
|
-- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BBP
Virtus LifeSci Biotech Products ETF
|
$79.36 | -- | -- | -- | $0.00 | 0% | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
$38.19 | -- | -- | -- | $0.24 | 0.63% | -- |
|
PFFR
InfraCap REIT Preferred ETF
|
$18.03 | -- | -- | -- | $0.12 | 7.99% | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
$45.70 | -- | -- | -- | $0.00 | 0.08% | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
$53.59 | -- | -- | -- | $0.03 | 0% | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
$50.15 | -- | -- | -- | $1.17 | 2.34% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | 0.818 | -- | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
-- | 1.813 | -- | -- |
|
PFFR
InfraCap REIT Preferred ETF
|
-- | 0.378 | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | 0.727 | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | 1.024 | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | 1.453 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
-- | -- | -- | -- | -- | -- |
|
PFFR
InfraCap REIT Preferred ETF
|
-- | -- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- | -- |
Virtus LifeSci Biotech Products ETF vs. Competitors
-
Which has Higher Returns BBP or BBC?
Virtus LifeSci Biotech Clinical Trials ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat Virtus LifeSci Biotech Clinical Trials ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- BBCVirtus LifeSci Biotech Clinical Trials ETF-- -- -- -
What do Analysts Say About BBP or BBC?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Clinical Trials ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than Virtus LifeSci Biotech Clinical Trials ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than Virtus LifeSci Biotech Clinical Trials ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 BBCVirtus LifeSci Biotech Clinical Trials ETF0 0 0 -
Is BBP or BBC More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.640, which suggesting that the stock is 35.974% less volatile than S&P 500. In comparison Virtus LifeSci Biotech Clinical Trials ETF has a beta of 0.983, suggesting its less volatile than the S&P 500 by 1.702%.
-
Which is a Better Dividend Stock BBP or BBC?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Virtus LifeSci Biotech Clinical Trials ETF offers a yield of 0.63% to investors and pays a quarterly dividend of $0.24 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Clinical Trials ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or BBC?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Clinical Trials ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than Virtus LifeSci Biotech Clinical Trials ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Clinical Trials ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for Virtus LifeSci Biotech Clinical Trials ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- BBCVirtus LifeSci Biotech Clinical Trials ETF-- -- -- --
-
Which has Higher Returns BBP or PFFR?
InfraCap REIT Preferred ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat InfraCap REIT Preferred ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- PFFRInfraCap REIT Preferred ETF-- -- -- -
What do Analysts Say About BBP or PFFR?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand InfraCap REIT Preferred ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than InfraCap REIT Preferred ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than InfraCap REIT Preferred ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 PFFRInfraCap REIT Preferred ETF0 0 0 -
Is BBP or PFFR More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.640, which suggesting that the stock is 35.974% less volatile than S&P 500. In comparison InfraCap REIT Preferred ETF has a beta of 0.717, suggesting its less volatile than the S&P 500 by 28.347%.
-
Which is a Better Dividend Stock BBP or PFFR?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfraCap REIT Preferred ETF offers a yield of 7.99% to investors and pays a quarterly dividend of $0.12 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. InfraCap REIT Preferred ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or PFFR?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than InfraCap REIT Preferred ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than InfraCap REIT Preferred ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while InfraCap REIT Preferred ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for InfraCap REIT Preferred ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- PFFRInfraCap REIT Preferred ETF-- -- -- --
-
Which has Higher Returns BBP or PSCH?
Invesco S&P SmallCap Health Care ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat Invesco S&P SmallCap Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -
What do Analysts Say About BBP or PSCH?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P SmallCap Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than Invesco S&P SmallCap Health Care ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than Invesco S&P SmallCap Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 PSCHInvesco S&P SmallCap Health Care ETF0 0 0 -
Is BBP or PSCH More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.640, which suggesting that the stock is 35.974% less volatile than S&P 500. In comparison Invesco S&P SmallCap Health Care ETF has a beta of 0.945, suggesting its less volatile than the S&P 500 by 5.48%.
-
Which is a Better Dividend Stock BBP or PSCH?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Invesco S&P SmallCap Health Care ETF offers a yield of 0.08% to investors and pays a quarterly dividend of $0.00 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. Invesco S&P SmallCap Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or PSCH?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than Invesco S&P SmallCap Health Care ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than Invesco S&P SmallCap Health Care ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while Invesco S&P SmallCap Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for Invesco S&P SmallCap Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- --
-
Which has Higher Returns BBP or PTH?
Invesco Dorsey Wright Healthcare Momentum ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -
What do Analysts Say About BBP or PTH?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Dorsey Wright Healthcare Momentum ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than Invesco Dorsey Wright Healthcare Momentum ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than Invesco Dorsey Wright Healthcare Momentum ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 -
Is BBP or PTH More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.640, which suggesting that the stock is 35.974% less volatile than S&P 500. In comparison Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.943, suggesting its less volatile than the S&P 500 by 5.68%.
-
Which is a Better Dividend Stock BBP or PTH?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Invesco Dorsey Wright Healthcare Momentum ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.03 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. Invesco Dorsey Wright Healthcare Momentum ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or PTH?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than Invesco Dorsey Wright Healthcare Momentum ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while Invesco Dorsey Wright Healthcare Momentum ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for Invesco Dorsey Wright Healthcare Momentum ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- --
-
Which has Higher Returns BBP or SBIO?
ALPS Medical Breakthroughs ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat ALPS Medical Breakthroughs ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- -
What do Analysts Say About BBP or SBIO?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Medical Breakthroughs ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than ALPS Medical Breakthroughs ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than ALPS Medical Breakthroughs ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 SBIOALPS Medical Breakthroughs ETF0 0 0 -
Is BBP or SBIO More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.640, which suggesting that the stock is 35.974% less volatile than S&P 500. In comparison ALPS Medical Breakthroughs ETF has a beta of 0.849, suggesting its less volatile than the S&P 500 by 15.057%.
-
Which is a Better Dividend Stock BBP or SBIO?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ALPS Medical Breakthroughs ETF offers a yield of 2.34% to investors and pays a quarterly dividend of $1.17 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. ALPS Medical Breakthroughs ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or SBIO?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than ALPS Medical Breakthroughs ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than ALPS Medical Breakthroughs ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while ALPS Medical Breakthroughs ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for ALPS Medical Breakthroughs ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 0.06% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 2.97% over the past day.
